Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases | Musculoskeletal | Rheumatology | Dermatology/Plastic Surgery
Disease Category: Lupus
Trial Information
Lupus Study for lupus patients who have lupus kidney disease
In some patients with lupus, certain types of white blood cells called lymphocytes make substances called double stranded DNA antibodies that may cause inflammation of the body’s own tissues. These double stranded DNA antibodies may also be associated with lupus kidney disease. The study drug is designed to remove the double stranded DNA antibodies from circulation. The study drug may also attach to certain white blood cells involved in making these antibodies. When the study drug was given to lupus subjects in earlier studies, double stranded DNA antibodies were lowered.
Patient Inclusion:
- Ages 12 to 70
- Diagnosed with systemic lupus
- Have had a kidney disease flare with the last 4 years
Patient Exclusion: None listed
John J. Condemi, M.D., Medical Director
AAIR Research Center
300 Meridian Centre, Suite 305
Rochester, NY 14618
Phone: 585-442-1980
Fax: 585-442-1585
EMail: research@aair.info
View Google Map
Research Center Information: AAIR Research Center
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
